Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid

Oliveira, Enedina Maria Lobato de; Montani, Daniela Antunes; Oliveira-Silva, Diogo; Rodrigues-Oliveira, André Filipe; Matas, Sandro Luiz de Andrade; Fernandes, Gustavo Bruniera Peres; Silva, Ismael Dale Cotrim Guerreiro da; Lo Turco, Edson Guimarães.
Arq. neuropsiquiatr ; 77(10): 696-704, Oct. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1038736

Documentos relacionados

  1. Can CSF biomarkers predict future MS disease activity and severity?
  2. Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF.
  3. Performance of McDonald 2017 multiple sclerosis diagnostic criteria and evaluation of genetic ancestry in patients with a first demyelinating event in Argentina.
  4. Laboratory Diagnosis of Intrathecal Synthesis of Immunoglobulins: A Review about the Contribution of OCBs and K-index.
  5. Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid.
  6. Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers.
  7. Potential Biomarkers Associated with Multiple Sclerosis Pathology.
  8. BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases.
  9. Pilot Study of the Total and Phosphorylated Tau Proteins in Early-Stage Multiple Sclerosis.
  10. Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis.